Paclitaxel and Carboplatin Treatment for Advanced Ovarian Cancer during Pregnancy

被引：12

作者：

Ramos, Jesus Ruiz ^{[1
]}

Roma, Eva ^{[1
]}

Palomar, Laura ^{[2
]}

Poveda, Jose Luis ^{[1
]}

机构：

[1] Dept Pharm, Valencia, Spain

[2] Oncol Dept HUP La Fe, Valencia, Spain

来源：

CHEMOTHERAPY | 2013年 / 59卷 / 05期

关键词：

Pregnancy; Chemotherapy; Ovary; PLATINUM DERIVATIVES; EPITHELIAL OVARIAN; CHEMOTHERAPY;

D O I：

10.1159/000360691

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Ovarian carcinoma during pregnancy is a rare event that should be treated. In these cases, due to the lack of information available, doubts about the safety of mother and fetus are present. In this report, a 42-year-old woman who was diagnosed with a stage III ovarian carcinoma received six cycles of chemotherapy with carboplatin and paclitaxel from the 16th until 36th week of gestation. At 38 weeks, a normal male baby was born. There were no abnormalities during birth and during a 2-month follow-up period. This case adds to the available literature and supports the use of these chemotherapy agents during pregnancy, if the risk-benefit balance is appropriate. (C) 2014 S. Karger AG, Basel

引用

页码：344 / 345

页数：2

共 9 条

[1] Safety and Outcome of Patients Treated with a Modified Outpatient Intraperitoneal Regimen for Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer [J].